Whitepapers

Executive Summary DMPK solutions are becoming central to faster discovery decisions because drug metabolism and pharmacokinetics (DMPK) studies guide compound progression by informing solubility, permeability,...

Explore Syngene’s nucleic acid therapeutics discovery platform for high-quality oligonucleotide programs. Read the white paper today.

Introduction In this exclusive interview Kenneth Barr, Senior Vice President – Research Services at Syngene International, sheds light on how Syngene is uniquely positioned to...

Introduction Biologics Outsourcing: From Option to Imperative The biologics revolution is in full swing, and as innovation accelerates, so does the complexity of bringing these...

Introduction In the race to decarbonize the global economy, advanced materials are no longer a luxury – they’re a necessity. The global specialty polymer market,...

Introduction The pharmaceutical industry has been forced to reckon with the increasing discovery of nitrosamine impurities in drugs, compounds known for their carcinogenic potential. This...

Introduction The global animal health market is a staggering $60 billion industry, projected to reach $100 billion by 2030. This phenomenal growth reflects a confluence...

Introduction Since the establishment of Chinese Hamster Ovary (CHO) cells in the 1950s, the production of therapeutic proteins has seen continuous innovation and growth. The...

Introduction The biopharmaceutical industry has been a hotbed of innovation in recent years, with an increasing number of novel recombinant protein therapeutics receiving the U.S....

Introduction The past 20 years have brought a new generation of cancer therapeutics designed to target tumor cells or cellular processes involved with tumor cell...